Overview
Richard Zelkowitz is a Hematologist Oncology specialist and a Hematologist in Bridgeport, Connecticut. Dr. Zelkowitz is rated as an Experienced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2800 Main St, Bridgeport, CT 06606
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.
Weill Medical College Of Cornell
John Allan is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Allan has been practicing medicine for over 16 years and is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Splenectomy.
Weill Medical College Of Cornell
Richard Furman is a Hematologist and an Oncologist in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Zelkowitz isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Zelkowitz isDistinguished. Learn about Breast Cancer.
- Breast Cancer in MenDr. Zelkowitz isDistinguished. Learn about Breast Cancer in Men.
- Inflammatory Breast CancerDr. Zelkowitz isDistinguished. Learn about Inflammatory Breast Cancer.
- Intraductal PapillomaDr. Zelkowitz isDistinguished. Learn about Intraductal Papilloma.
- Paget Disease of the BreastDr. Zelkowitz isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Acquired Amegakaryocytic Thrombocytopenia
- Congenital Aplastic AnemiaDr. Zelkowitz isAdvanced. Learn about Congenital Aplastic Anemia.
- DICER1 SyndromeDr. Zelkowitz isAdvanced. Learn about DICER1 Syndrome.
- HER-2 Positive Breast CancerDr. Zelkowitz isAdvanced. Learn about HER-2 Positive Breast Cancer.
- Pleuropulmonary BlastomaDr. Zelkowitz isAdvanced. Learn about Pleuropulmonary Blastoma.
- Triple-Negative Breast CancerDr. Zelkowitz isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- AgranulocytosisDr. Zelkowitz isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Zelkowitz isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Zelkowitz isExperienced. Learn about Anemia.
- Ataxia-Pancytopenia SyndromeDr. Zelkowitz isExperienced. Learn about Ataxia-Pancytopenia Syndrome.
- Blood ClotsDr. Zelkowitz isExperienced. Learn about Blood Clots.
- BRCA Positive Breast CancerDr. Zelkowitz isExperienced. Learn about BRCA Positive Breast Cancer.